首页> 美国卫生研究院文献>SAGE Open Medical Case Reports >Sustained drug retention after paclitaxel-coated balloon angioplasty for superficial femoral artery disease: Follow-up intravascular imaging
【2h】

Sustained drug retention after paclitaxel-coated balloon angioplasty for superficial femoral artery disease: Follow-up intravascular imaging

机译:紫杉醇涂层球囊血管成形术治疗股骨浅表疾病后的持续药物保留:后续血管内成像

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 63 year-old woman with claudication underwent endovascular therapy for diffuse stenosis of the right superficial femoral artery in our hospital. We performed paclitaxel-coated balloon angioplasty using the IN.PACT™ Admiral™ and achieved acceptable results. After 42 days, we performed follow-up optical frequency domain imaging for the right superficial femoral artery lesion treated with paclitaxel-coated balloon and observed several high-intensity regions with attenuation on the lumen surface. Sustained drug availability is a notable characteristic of paclitaxel-coated balloon. To the best of our knowledge, this is the first report on the visualization of sustained drug retention on the lumen surface using follow-up optical frequency domain imaging after paclitaxel-coated balloon angioplasty in a human patient with superficial femoral artery disease.
机译:我院一名63岁c行woman行的妇女因右股浅动脉弥漫性狭窄接受了血管内治疗。我们使用IN.PACT™Admiral™进行了紫杉醇涂层的球囊血管成形术,并获得了可接受的结果。 42天后,我们对紫杉醇涂层球囊治疗的右股浅动脉病变进行了后续的光学频域成像,并观察到了一些高强度区域,其内腔表面均有衰减。持续的药物可用性是紫杉醇涂层球囊的显着特征。据我们所知,这是首次报告使用紫杉醇涂层的球囊血管成形术在患有股浅动脉疾病的人类患者中使用后续的光学频域成像技术对内腔表面的药物持续滞留进行可视化。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号